Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2003 2
2004 2
2005 2
2006 2
2007 3
2008 5
2009 8
2010 3
2011 5
2012 9
2013 6
2014 4
2015 5
2016 4
2017 8
2018 4
2019 3
2020 7
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

80 results
Results by year
Filters applied: . Clear all
Page 1
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189509 Clinical Trial.
Virus maturation.
Delgui LR, Rodríguez JF. Delgui LR, et al. Among authors: rodriguez jf. Subcell Biochem. 2013;68:395-415. doi: 10.1007/978-94-007-6552-8_13. Subcell Biochem. 2013. PMID: 23737059 Review.
Cobalt-Catalyzed Enantioselective Hydroarylation of 1,6-Enynes.
Whyte A, Torelli A, Mirabi B, Prieto L, Rodríguez JF, Lautens M. Whyte A, et al. Among authors: rodriguez jf. J Am Chem Soc. 2020 May 20;142(20):9510-9517. doi: 10.1021/jacs.0c03246. Epub 2020 May 7. J Am Chem Soc. 2020. PMID: 32337994
Patch organization and resilience of dryland wetlands.
Sandi SG, Saco PM, Rodriguez JF, Saintilan N, Wen L, Kuczera G, Riccardi G, Willgoose G. Sandi SG, et al. Among authors: rodriguez jf. Sci Total Environ. 2020 Jul 15;726:138581. doi: 10.1016/j.scitotenv.2020.138581. Epub 2020 Apr 12. Sci Total Environ. 2020. PMID: 32348947
Type I Interferon acts as a major barrier to the establishment of infectious bursal disease virus (IBDV) persistent infections.
Broto L, Romero N, Méndez F, Diaz-Beneitez E, Candelas-Rivera O, Fuentes D, Cubas-Gaona LL, Courtillon C, Eterradossi N, Soubies SM, Rodríguez JR, Rodríguez D, Rodríguez JF. Broto L, et al. Among authors: rodriguez jf. J Virol. 2020 Dec 16;95(5):e02017-20. doi: 10.1128/JVI.02017-20. Online ahead of print. J Virol. 2020. PMID: 33328313 Free PMC article.
80 results